bioAffinity Technologies GAAP EPS of -$5.89, revenue of $1.1M
- bioAffinity Technologies press release (BIAF): Q3 GAAP EPS of -$5.89.
- Revenue of $1.1M (-21.4% Y/Y).
- Cash and cash equivalents of approximately $2.6M as of September 30, 2026, compared with $6.4M as of December 31, 2025.
Recommended For You
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Create Your Free Account to Keep Reading
Get the confidence to navigate an uncertain market with free breaking news and stock alerts.
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.